Home › Free Stock Grades › ABSI
Absci Corporation (ABSI) Stock Grade
ABSI · Healthcare
C
Market Cap
$1.6B
P/E Ratio
—
Revenue Growth (YoY)
-38.2%
Net Margin
-4113.7%
Return on Equity
—
Dividend Yield
None
About Absci Corporation's fundamentals
Absci Corporation is a biotechnology company with a market capitalization of $1.6 billion that is currently unprofitable, reporting a significant net loss in its latest annual statement with a net margin of -4113.7%. The company experienced steep revenue decline, with year-over-year revenue falling 38.2%, indicating contracting business activity. Absci does not pay a dividend, and traditional valuation metrics like P/E ratio and return on equity are not meaningful given the company's loss-making status.